Patients undergoing BRAF/MEK inhibitor therapy for melanoma more commonly experience VKH-like uveitis compared with other malignancy types.

Pharmacokinetics studies how a drug is absorbed into the body over time — how it gets distributed through the blood and to ...

EMA accepts for review GSK’s application to expand use of Nucala for COPD treatment: London, UK Wednesday, March 26, 2025, 11:00 Hrs [IST] GSK plc announced that the European Me ...

In the wild, dogs spend a lot of their time chewing on bones, carcasses, sticks and kernels. For example, Australian dingoes ...

The following is a summary of "Worsening disease severity as measured by I-SEE associates with decreased treatment response ...

Explore 10 facts about fractures, from how bones naturally heal to breakthrough treatments. Learn essential recovery ...

Objective Asthma and type 2 diabetes are two important causes of morbidity globally. We examined both the association of type ...

Exelixis, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved CABOMETYX® (cabozantinib) for the treatment of 1) adult and pediatric patients 12 years of age and older ...

TMJ treatment usually involves multiple approaches to release jaw and muscle tension. Learn how self-care, medication, and ...

Glaucoma is a group of diseases that damages the optic nerve of the eye resulting in vision loss and eventually irreversible ...

Insmed Incorporated , a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced ...